Epithelial damage in the cystic fibrosis lung: the role of host and microbial factors

References

• De Rose V, Molloy K, and Gohy S, et al. Airway epithelium dysfunction in cystic fibrosis and COPD. Mediators Inflamm. 2018;2018;1309746–1309766.
   PubMed Web of Science ®Google Scholar
• Zajac M, Dreano E, Edwards A, et al. Airway surface liquid pH regulation in airway epithelium current understandings and gaps in knowledge. Int J Mol Sci. 2021;23:22.
   PubMedGoogle Scholar
• Ismailov IL, Awayda MS, Jovov B, et al. Regulation of epithelial sodium channels by the cystic fibrosis transmembrane conductance regulator. J Biol Chem. 1996;271:4725–4732.
   PubMed Web of Science ®Google Scholar
• Ghosh A, Boucher RC, Tarran R. Airway hydration and COPD. Cell Mol Life Sci. 2015;72:3637–3652.
   PubMed Web of Science ®Google Scholar
• Button B, Cai LH, Ehre C, et al. A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia. Science. 2012;337:937–941.
   PubMed Web of Science ®Google Scholar
• Tang XX, Ostedgaard LS, Hoegger MJ, et al. Acidic pH increases airway surface liquid viscosity in cystic fibrosis. J Clin Invest. 2016;126:879–891.
   PubMed Web of Science ®Google Scholar
• Alaiwa MHA, Reznikov LR, Gansemer ND, et al. pH modulates the activity and synergism of the airway surface liquid antimicrobials β-defensin-3 and LL-37. Proc Natl Acad Sci USA. 2014;111:18703–18708.
   PubMed Web of Science ®Google Scholar
• Pezzulo AA, Tang XX, Hoegger MJ, et al. Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature. 2012;487:109–113.
   PubMed Web of Science ®Google Scholar
• Garland AL, Walton WG, Coakley RD, et al. Molecular basis for pH-dependent mucosal dehydration in cystic fibrosis airways. Proc Natl Acad Sci USA. 2013;110:15973–15978.
   PubMed Web of Science ®Google Scholar
• Kim CS, Ahmad S, Wu T, et al. SPLUNC1 is an allosteric modulator of the epithelial sodium channel. FASEB J. 2018;32:2478–2491.
   PubMed Web of Science ®Google Scholar
• Adam D, Roux-Delrieu J, Luczka E, et al. Cystic fibrosis airway epithelium remodelling: involvement of inflammation. J Pathol. 2015;235:408–419.
   PubMed Web of Science ®Google Scholar
• Ferrera L, Capurro V, Delpiano L, et al. The application of bicarbonate recovers the chemical-physical properties of airway surface liquid in cystic fibrosis epithelia models. Biology (Basel). 2021;10:278.
   PubMedGoogle Scholar
• Morrison CB, Shaffer KM, Araba KC, et al. Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus properties via hydration. Eur Respir J. 2022;59:2100185.
   PubMed Web of Science ®Google Scholar
• de Dios Caballero J, Vida R, Cobo M, et al. Individual patterns of complexity in cystic fibrosis lung microbiota, including predator bacteria, over a 1-year period. MBio. 2017;8:e00959–17.
   PubMed Web of Science ®Google Scholar
• Surette MG. The cystic fibrosis lung microbiome. Ann Am Thorac Soc. 2014;11:S61–5.
   PubMedGoogle Scholar
• Kiedrowski MR, Bomberger JM. Viral-bacterial co-infections in the cystic fibrosis respiratory tract. Front Immunol. 2018;9:3067.
   PubMed Web of Science ®Google Scholar
• Malhotra S, Hayes D, Wozniak DJ. Cystic fibrosis and pseudomonas aeruginosa: the host-microbe interface. Clin Microbiol Rev. 2019;32:e00138–18.
   PubMed Web of Science ®Google Scholar
• Chmiel JF, Aksamit TR, Chotirmall SH, et al. Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections. Ann Am Thorac Soc. 2014;11:1120–1129.
   PubMedGoogle Scholar
• Turcios NL. Cystic fibrosis lung disease: an overview. Respir Care. 2020;65:233–251.
   PubMed Web of Science ®Google Scholar
• Zemanick ET, Harris JK, Wagner BD, et al. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations. PLoS One. 2013;8:e62917.
   PubMed Web of Science ®Google Scholar
• Laarman AJ, Bardoel BW, Ruyken M, et al. Pseudomonas aeruginosa alkaline protease blocks complement activation via the classical and lectin pathways. J Immunol. 2012;188:386–393.
   PubMed Web of Science ®Google Scholar
• Allen L, Dockrell DH, Pattery T, et al. Pyocyanin production by Pseudomonas aeruginosa induces neutrophil apoptosis and impairs neutrophil-mediated host defenses in vivo. J Immunol. 2005;174:3643–3649.
   PubMed Web of Science ®Google Scholar
• Alhede M, Bjarnsholt T, Jensen P, et al. Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes. Microbiology. 2009;155:3500–3508.
   PubMed Web of Science ®Google Scholar
• Hassett DJ, Cohen MS. Bacterial adaptation to oxidative stress: implications for pathogenesis and interaction with phagocytic cells. FASEB J. 1989;3:2574–2582.
   PubMed Web of Science ®Google Scholar
• Britigan BE, Miller RA, Hassett DJ, et al. Antioxidant enzyme expression in clinical isolates of Pseudomonas aeruginosa: identification of an atypical form of manganese superoxide dismutase. Infect Immun. 2001;69:7396–7401.
   PubMed Web of Science ®Google Scholar
• Heck LW, Morihara K, McRae WB, et al. Specific cleavage of human type III and IV collagens by Pseudomonas aeruginosa elastase. Infect Immun. 1986;51:115–118.
   PubMedGoogle Scholar
• Golovkine G, Faudry E, Bouillot S, et al. VE-cadherin cleavage by LasB protease from Pseudomonas aeruginosa facilitates type III secretion system toxicity in endothelial cells. PLoS Pathog. 2014;10:e1003939.
   PubMed Web of Science ®Google Scholar
• Ruffin M, Bilodeau C, Mailĺe É, et al. Quorum-sensing inhibition abrogates the deleterious impact of Pseudomonas aeruginosa on airway epithelial repair. FASEB J. 2016;30:3011–3025.
   PubMed Web of Science ®Google Scholar
• Saint-Criq V, Villeret B, Bastaert F, et al. Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator-IL-6-antimicrobial-repair pathway. Thorax. 2018;73:49–61.
   PubMed Web of Science ®Google Scholar
• Britigan BE, Hayek MB, Doebbeling BN, et al. Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis. Infect Immun. 1993;61:5049–5055.
   PubMed Web of Science ®Google Scholar
• Bastaert F, Kheir S, Saint-Criq V, et al. Pseudomonas aeruginosa LasB subverts alveolar macrophage activity by interfering with bacterial killing through downregulation of innate immune defense, reactive oxygen species generation, and complement activation. Front Immunol. 2018;9. DOI:10.3389/fimmu.2018.01675.
   PubMed Web of Science ®Google Scholar
• Hogardt M, Heesemann J. Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. Int J Med Microbiol. 2010;300:557–562.
   PubMed Web of Science ®Google Scholar
• Cobb LM, Mychaleckyj JC, Wozniak DJ, et al. Pseudomonas aeruginosa flagellin and alginate elicit very distinct gene expression patterns in airway epithelial cells: implications for cystic fibrosis disease. J Immunol. 2004;173:5659–5670.
   PubMed Web of Science ®Google Scholar
• Lovewell RR, Hayes SM, O’Toole GA, et al. Pseudomonas aeruginosa flagellar motility activates the phagocyte PI3K/Akt pathway to induce phagocytic engulfment. Am J Physiol Lung Cell Mol Physiol. 2014;306:L698–707.
   PubMed Web of Science ®Google Scholar
• Floyd M, Winn M, Cullen C, et al. Swimming motility mediates the formation of neutrophil extracellular traps induced by flagellated Pseudomonas aeruginosa. PLoS Pathog. 2016;12:e1005987.
   PubMed Web of Science ®Google Scholar
• Jesaitis AJ, Franklin MJ, Berglund D, et al. Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions. J Immunol. 2003;171:4329–4339.
   PubMed Web of Science ®Google Scholar
• Caceres SM, Malcolm KC, Taylor-Cousar JL, et al. Enhanced in vitro formation and antibiotic resistance of nonattached Pseudomonas aeruginosa aggregates through incorporation of neutrophil products. Antimicrob Agents Chemother. 2014;58:6851–6860.
   PubMed Web of Science ®Google Scholar
• Xie ZD, Hershberger CD, Shankar S, et al. Sigma factor-anti-sigma factor interaction in alginate synthesis: inhibition of AlgT by MucA. J Bacteriol. 1996;178:4990–4996.
   PubMed Web of Science ®Google Scholar
• Farrell PM, Collins J, Broderick LS, et al. Association between mucoid Pseudomonas infection and bronchiectasis in children with cystic fibrosis. Radiology. 2009;252:534–543.
   PubMed Web of Science ®Google Scholar
• Rojas LJ, Yasmin M, Benjamino J, et al. Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: a population-level analysis beyond susceptibility testing. PLoS One. 2022;17:e0265129.
   PubMed Web of Science ®Google Scholar
• Marvig RL, Sommer LM, Jelsbak L, et al. Evolutionary insight from whole-genome sequencing of Pseudomonas aeruginosa from cystic fibrosis patients. Future Microbiol. 2015;10:599–611.
   PubMed Web of Science ®Google Scholar
• Pier GB, Coleman F, Grout M, et al. Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis. Infect Immun. 2001;69:1895–1901.
   PubMed Web of Science ®Google Scholar
• Young RL, Malcolm KC, Kret JE, et al. Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR. PLoS One. 2011;6:e23637.
   PubMed Web of Science ®Google Scholar
• Mathee K, Ciofu O, Sternberg C, et al. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology. 1999;145(Pt 6):1349–1357.
   PubMed Web of Science ®Google Scholar
• Limoli DH, Rockel AB, Host KM, et al. Cationic antimicrobial peptides promote microbial mutagenesis and pathoadaptation in chronic infections. PLoS Pathog. 2014;10:e1004083.
   PubMed Web of Science ®Google Scholar
• Mori M, Tsunemine H, Imada K, et al. Life-threatening hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in the treatment of hematologic diseases. Ann Hematol. 2014;93:901–911.
   PubMed Web of Science ®Google Scholar
• Wettlaufer J, Klingel M, Yau Y, et al. Longitudinal study of Stenotrophomonas maltophilia antibody levels and outcomes in cystic fibrosis patients. J Cyst Fibros. 2017;16:58–63.
   PubMedGoogle Scholar
• Windhorst S, Frank E, Georgieva DN, et al. The major extracellular protease of the nosocomial pathogen Stenotrophomonas maltophilia: characterization of the protein and molecular cloning of the gene. J Biol Chem. 2002;277:11042–11049.
   PubMed Web of Science ®Google Scholar
• DuMont AL, Karaba SM, Cianciotto NP. Type II secretion-dependent degradative and cytotoxic activities mediated by Stenotrophomonas maltophilia serine proteases StmPr1 and StmPr2. Infect Immun. 2015;83:3825–3837.
   PubMed Web of Science ®Google Scholar
• DuMont AL, Cianciotto NP. Stenotrophomonas maltophilia serine protease StmPr1 induces matrilysis, Anoikis, and protease-activated receptor 2 activation in human lung epithelial cells. Infect Immun. 2017;85:e00544–17.
   PubMed Web of Science ®Google Scholar
• Molloy K, Cagney G, Dillon ET, et al. Impaired airway epithelial barrier integrity in response to Stenotrophomonas maltophilia proteases, novel insights using cystic fibrosis bronchial epithelial cell secretomics. Front Immunol. 2020;11. DOI:10.3389/fimmu.2020.00011.
   PubMed Web of Science ®Google Scholar
• Molloy K, Smith SG, Cagney G, et al. Characterisation of the major extracellular proteases of Stenotrophomonas maltophilia and their effects on pulmonary antiproteases. Basel (Switzerland): Pathog; 2019. p. 8.
   Google Scholar
• Konstan MW, Hilliard KA, Norvell TM, et al. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med. 1994;150:448–454.
   PubMed Web of Science ®Google Scholar
• Taggart C, Coakley RJ, Greally P, et al. Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-alpha and interleukin-8. Am J Physiol Lung Cell Mol Physiol. 2000;278:L33–41.
   PubMed Web of Science ®Google Scholar
• Dittrich AS, Kühbandner I, and Gehrig S, et al. Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis. Eur Respir J. 2018;51:1701910–1701921 .
   PubMed Web of Science ®Google Scholar
• Margaroli C, Garratt LW, Horati H, et al. Elastase exocytosis by airway neutrophils is associated with early lung damage in children with cystic fibrosis. Am J Respir Crit Care Med. 2019;199:873–881.
   PubMed Web of Science ®Google Scholar
• Goldstein W, Doring G. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis. Am Rev Respir Dis. 1986;134:49–56.
   PubMed Web of Science ®Google Scholar
• Guerra M, Frey D, Hagner M, et al. Cathepsin G activity as a new marker for detecting airway inflammation by microscopy and flow cytometry. ACS Cent Sci. 2019;5:539–548.
   PubMedGoogle Scholar
• Witko-Sarsat V, Halbwachs-Mecarelli L, Schuster A, et al. Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum. Am J Respir Cell Mol Biol. 1999;20:729–736.
   PubMed Web of Science ®Google Scholar
• Sagel SD, Sontag MK, Wagener JS, et al. Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis. J Pediatr. 2002;141:811–817.
   PubMed Web of Science ®Google Scholar
• Sly PD, Gangell CL, Chen L, et al. Risk factors for bronchiectasis in children with cystic fibrosis. N Engl J Med. 2013;368:1963–1970.
   PubMed Web of Science ®Google Scholar
• Cantin A, Bilodeau G, Bégin R. Granulocyte elastase‐mediated proteolysis of alpha1‐antitrypsin in cystic fibrosis bronchopulmonary secretions. Pediatr Pulmonol. 1989;7:12–17.
   PubMedGoogle Scholar
• Weldon S, McNally P, McElvaney NG, et al. Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation. J Immunol. 2009;183:8148–8156.
   PubMed Web of Science ®Google Scholar
• Guyot N, Butler MW, McNally P, et al. Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis. J Biol Chem. 2008;283:32377–32385.
   PubMed Web of Science ®Google Scholar
• Rubio F, Cooley J, Accurso FJ, et al. Linkage of neutrophil serine proteases and decreased surfactant protein-A (SP-A) levels in inflammatory lung disease. Thorax. 2004;59:318–323.
   PubMed Web of Science ®Google Scholar
• López-Boado YS, Espinola M, Bahr S, et al. Neutrophil serine proteinases cleave bacterial flagellin, abrogating its host response-inducing activity. J Immunol. 2004;172:509–515.
   PubMed Web of Science ®Google Scholar
• Sonawane A, Jyot J, During R, et al. Neutrophil elastase, an innate immunity effector molecule, represses flagellin transcription in Pseudomonas aeruginosa. Infect Immun. 2006;74:6682–6689.
   PubMed Web of Science ®Google Scholar
• Fischer BM, Domowicz DAL, Zheng S, et al. Neutrophil elastase increases airway epithelial nonheme iron levels. Clin Transl Sci. 2009;2:333–339.
   PubMed Web of Science ®Google Scholar
• Tosi MF, Zakem H, Berger M. Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. J Clin Invest. 1990;86:300–308.
   PubMed Web of Science ®Google Scholar
• van den Berg CW, Tambourgi DV, Clark HW, et al. Mechanism of neutrophil dysfunction: neutrophil serine proteases cleave and inactivate the C5a receptor. J Immunol. 2014;192:1787–1795.
   PubMed Web of Science ®Google Scholar
• Vandivier RW, Fadok VA, Hoffmann PR, et al. Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J Clin Invest. 2002;109:661–670.
   PubMed Web of Science ®Google Scholar
• Döring G, Frank F, Boudier C, et al. Cleavage of lymphocyte surface antigens CD2, CD4, and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis. J Immunol. 1995;154:4842–4850.
   PubMed Web of Science ®Google Scholar
• Le-Barillec K, Si-Tahar M, Balloy V, et al. Proteolysis of monocyte CD14 by human leukocyte elastase inhibits lipopolysaccharide-mediated cell activation. J Clin Invest. 1999;103:1039–1046.
   PubMed Web of Science ®Google Scholar
• Roghanian A, Drost EM, MacNee W, et al. Inflammatory lung secretions inhibit dendritic cell maturation and function via neutrophil elastase. Am J Respir Crit Care Med. 2006;174:1189–1198.
   PubMedGoogle Scholar
• Papayannopoulos V, Metzler KD, Hakkim A, et al. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol. 2010;191:677–691.
   PubMed Web of Science ®Google Scholar
• Dubois AV, Gauthier A, Bréa D, et al. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum. Am J Respir Cell Mol Biol. 2012;47:80–86.
   PubMed Web of Science ®Google Scholar
• Kummarapurugu AB, Zheng S, Ma J, et al. Neutrophil elastase triggers the release of macrophage extracellular traps: relevance to cystic fibrosis. Am J Respir Cell Mol Biol. 2021;66:76–85.
   Web of Science ®Google Scholar
• Park JA, Sharif AS, Shiomi T, et al. Human neutrophil elastase-mediated goblet cell metaplasia is attenuated in TACE-deficient mice. Am J Physiol Lung Cell Mol Physiol. 2013;304:L701–7.
   PubMed Web of Science ®Google Scholar
• Shao MXG, Nadel JA. Neutrophil elastase induces MUC5AC mucin production in human airway epithelial cells via a cascade involving protein kinase C, reactive oxygen species, and TNF-alpha-converting enzyme. J Immunol. 2005;175:4009–4016.
   PubMed Web of Science ®Google Scholar
• Park JA, He F, Martin LD, et al. Human neutrophil elastase induces hypersecretion of mucin from well-differentiated human bronchial epithelial cells in vitro via a protein kinase C{delta}-mediated mechanism. Am J Pathol. 2005;167:651–661.
   PubMed Web of Science ®Google Scholar
• Amitani R, Wilson R, Rutman A, et al. Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium. Am J Respir Cell Mol Biol. 1991;4:26–32.
   PubMed Web of Science ®Google Scholar
• Le Gars M, Descamps D, Roussel D, et al. Neutrophil elastase degrades cystic fibrosis transmembrane conductance regulator via calpains and disables channel function in vitro and in vivo. Am J Respir Crit Care Med. 2013;187:170–179.
   PubMed Web of Science ®Google Scholar
• Caldwell RA, Boucher RC, Stutts MJ. Neutrophil elastase activates near-silent epithelial Na+ channels and increases airway epithelial Na+ transport. Am J Physiol Lung Cell Mol Physiol. 2005;288:L813–9.
   PubMed Web of Science ®Google Scholar
• Nakamura H, Yoshimura K, McElvaney NG, et al. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J Clin Invest. 1992;89:1478–1484.
   PubMed Web of Science ®Google Scholar
• Bergin DA, Greene CM, Sterchi EE, et al. Activation of the epidermal growth factor receptor (EGFR) by a novel metalloprotease pathway. J Biol Chem. 2008;283:31736–31744.
   PubMed Web of Science ®Google Scholar
• Walsh DE, Greene CM, Carroll TP, et al. Interleukin-8 up-regulation by neutrophil elastase is mediated by MyD88/IRAK/TRAF-6 in human bronchial epithelium. J Biol Chem. 2001;276:35494–35499.
   PubMed Web of Science ®Google Scholar
• Carroll TP, Greene CM, Taggart CC, et al. Viral inhibition of IL-1- and neutrophil elastase-induced inflammatory responses in bronchial epithelial cells. J Immunol. 2005;175:7594–7601.
   PubMed Web of Science ®Google Scholar
• Hartl D, Latzin P, Hordijk P, et al. Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med. 2007;13:1423–1430.
   PubMed Web of Science ®Google Scholar
• Geraghty P, Rogan MP, Greene CM, et al. Neutrophil elastase up-regulates cathepsin B and matrix metalloprotease-2 expression. J Immunol. 2007;178:5871–5878.
   PubMed Web of Science ®Google Scholar
• Gaggar A, Li Y, Weathington N, et al. Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients. Am J Physiol Lung Cell Mol Physiol. 2007;293:L96–104.
   PubMed Web of Science ®Google Scholar
• Wolters PJ, Chapman HA. Importance of lysosomal cysteine proteases in lung disease. Respir Res. 2000;1:170–177.
   PubMedGoogle Scholar
• Taggart CC, Lowe GJ, Greene CM, et al. Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor. J Biol Chem. 2001;276:33345–33352.
   PubMed Web of Science ®Google Scholar
• Taggart CC, Greene CM, Smith SG, et al. Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins. J Immunol. 2003;171:931–937.
   PubMed Web of Science ®Google Scholar
• Rogan MP, Taggart CC, Greene CM, et al. Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis. J Infect Dis. 2004;190:1245–1253.
   PubMed Web of Science ®Google Scholar
• Lecaille F, Naudin C, Sage J, et al. Specific cleavage of the lung surfactant protein A by human cathepsin S may impair its antibacterial properties. Int J Biochem Cell Biol. 2013;45:1701–1709.
   PubMed Web of Science ®Google Scholar
• Andrault PM, Samsonov SA, Weber G, et al. Antimicrobial peptide LL-37 is both a substrate of cathepsins S and K and a selective inhibitor of cathepsin L. Biochemistry. 2015;54:2785–2798.
   PubMed Web of Science ®Google Scholar
• Repnik U, Starr AE, Overall CM, et al. Cysteine cathepsins activate ELR chemokines and inactivate non-ELR chemokines. J Biol Chem. 2015;290:13800–13811.
   PubMed Web of Science ®Google Scholar
• Haerteis S, Krappitz M, Bertog M, et al. Proteolytic activation of the epithelial sodium channel (ENaC) by the cysteine protease cathepsin-S. Pflugers Arch. 2012;464:353–365.
   PubMed Web of Science ®Google Scholar
• Tan CD, Hobbs C, Sameni M, et al. Cathepsin B contributes to Na+ hyperabsorption in cystic fibrosis airway epithelial cultures. J Physiol. 2014;592:5251–5268.
   PubMed Web of Science ®Google Scholar
• Weldon S, McNally P, McAuley DF, et al. miR-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary cathepsin S production. Am J Respir Crit Care Med. 2014;190:165–174.
   PubMed Web of Science ®Google Scholar
• Martin SL, Moffitt KL, McDowell A, et al. Association of airway cathepsin B and S with inflammation in cystic fibrosis. Pediatr Pulmonol. 2010;45:860–868.
   PubMed Web of Science ®Google Scholar
• Hentschel J, Fischer N, Janhsen WK, et al. Protease-antiprotease imbalances differ between cystic fibrosis patients’ upper and lower airway secretions. J Cyst Fibros. 2015;14:324–333.
   PubMed Web of Science ®Google Scholar
• Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001;17:463–516.
   PubMed Web of Science ®Google Scholar
• Gaggar A, Hector A, Bratcher PE, et al. The role of matrix metalloproteinases in cystic fibrosis lung disease. Eur Respir J. 2011;38:721–727.
   PubMed Web of Science ®Google Scholar
• Guyot N, Wartelle J, Malleret L, et al. Unopposed cathepsin G, neutrophil elastase, and proteinase 3 cause severe lung damage and emphysema. Am J Pathol. 2014;184:2197–2210.
   PubMed Web of Science ®Google Scholar
• Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007;8:221.
   PubMed Web of Science ®Google Scholar
• Bergin DA, Hurley K, Mehta A, et al. Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis. J Inflamm Res. 2013;6:1.
   PubMedGoogle Scholar
• Duszyk M, Shu Y, Sawicki G, et al. Inhibition of matrix metalloproteinase MMP-2 activates chloride current in human airway epithelial cells. Can J Physiol Pharmacol. 1999;77:529–535.
   PubMed Web of Science ®Google Scholar
• Ratjen F, Hartog CM, Paul K, et al. Matrix metalloproteases in BAL fluid of patients with cystic fibrosis and their modulation by treatment with dornase alpha. Thorax. 2002;57:930–934.
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Fernández A, Inada M, Balbín M, et al. Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8). FASEB J. 2007;21:2580–2591.
   PubMed Web of Science ®Google Scholar
• Gaggar A, Jackson PL, Noerager BD, et al. A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation. J Immunol. 2008;180:5662–5669.
   PubMed Web of Science ®Google Scholar
• Turnbull AR, Pyle CJ, Patel DF, et al. Abnormal pro-gly-pro pathway and airway neutrophilia in pediatric cystic fibrosis. J Cyst Fibros. 2020;19:40.
   PubMed Web of Science ®Google Scholar
• Bove PF, Wesley UV, Greul AK, et al. Nitric oxide promotes airway epithelial wound repair through enhanced activation of MMP-9. Am J Respir Cell Mol Biol. 2007;36:138–146.
   PubMed Web of Science ®Google Scholar
• Van Den Steen PE, Proost P, Wuyts A, et al. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-α and leaves RANTES and MCP-2 intact. Blood. 2000;96:2673–2681.
   PubMed Web of Science ®Google Scholar
• Van Den Steen PE, Wuyts A, Husson SJ, et al. Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. Eur J Biochem. 2003;270:3739–3749.
   PubMedGoogle Scholar
• Sagel SD, Kapsner RK, Osberg I. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis. Pediatr Pulmonol. 2005;39:224–232.
   PubMed Web of Science ®Google Scholar
• Garratt LW, Sutanto EN, Ling KM, et al. Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis. Eur Respir J. 2015;46:384–394.
   PubMed Web of Science ®Google Scholar
• DaSilva AG, Yong VW. Expression and regulation of matrix metalloproteinase-12 in experimental autoimmune encephalomyelitis and by bone marrow derived macrophages in vitro. J Neuroimmunol. 2008;199:24–34.
   PubMed Web of Science ®Google Scholar
• Dean RA, Cox JH, Bellac CL, et al. Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, −7, −8, and −13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx. Blood. 2008;112:3455–3464.
   PubMed Web of Science ®Google Scholar
• Houghton AMG, Hartzell WO, Robbins CS, et al. Macrophage elastase kills bacteria within murine macrophages. Nature. 2009;460:637–641.
   PubMed Web of Science ®Google Scholar
• Trojanek JB, Cobos-Correa A, Diemer S, et al. Airway mucus obstruction triggers macrophage activation and matrix metalloproteinase 12-dependent emphysema. Am J Respir Cell Mol Biol. 2014;51:709–720.
   PubMed Web of Science ®Google Scholar
• Li Q, Park PW, Wilson CL, et al. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell. 2002;111:635–646.
   PubMed Web of Science ®Google Scholar
• Dunsmore SE, Saarialho-Kere UK, Roby JD, et al. Matrilysin expression and function in airway epithelium. J Clin Invest. 1998;102:1321–1331.
   PubMed Web of Science ®Google Scholar
• Chen P, Abacherli LE, Nadler ST, et al. MMP7 shedding of syndecan-1 facilitates re-epithelialization by affecting alpha(2)beta(1) integrin activation. PLoS One. 2009;4:e6565.
   PubMed Web of Science ®Google Scholar
• McMahan RS, Birkland TP, Smigiel KS, et al. Stromelysin-2 (MMP10) moderates inflammation by controlling macrophage activation. J Immunol. 2016;197:899.
   PubMed Web of Science ®Google Scholar
• Oglesby IK, Bray IM, Chotirmall SH, et al. miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression. J Immunol. 2010;184:1702–1709.
   PubMed Web of Science ®Google Scholar
• Glasgow AMA, De Santi C, Greene CM. Non-coding RNA in cystic fibrosis. Biochem Soc Trans. 2018;46:619–630. BST20170469.
   PubMed Web of Science ®Google Scholar
• Lutful Kabir F, Ambalavanan N, Liu G, et al. microRNA-145 antagonism reverses TGF-β inhibition of F508del CFTR correction in airway epithelia. Am J Respir Crit Care Med. 2017;197:632–643. rccm.201704-0732OC.
   Web of Science ®Google Scholar
• Sonneville F, Ruffin M, Coraux C, et al. MicroRNA-9 downregulates the ANO1 chloride channel and contributes to cystic fibrosis lung pathology. Nat Commun. 2017;8:710.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Balakathiresan NS, Dalgard C, et al. Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin-8. J Biol Chem. 2011;286:11604–11615.
   PubMed Web of Science ®Google Scholar
• Oglesby IK, Vencken SF, Agrawal R, et al. miR-17 overexpression in cystic fibrosis airway epithelial cells decreases interleukin-8 production. Eur Respir J. 2015;46:1350–1360.
   PubMed Web of Science ®Google Scholar
• Bardin P, Marchal-Duval E, Sonneville F, et al. Small RNA and transcriptome sequencing reveal the role of miR-199a-3p in inflammatory processes in cystic fibrosis airways. J Pathol. 2018;245:410–420.
   PubMed Web of Science ®Google Scholar
• Bardin P, Foussignière T, Rousselet N, et al. miR-636: a newly-identified actor for the regulation of pulmonary inflammation in cystic fibrosis. Front Immunol. 2019;10. DOI:10.3389/fimmu.2019.02643.
   PubMed Web of Science ®Google Scholar
• Oglesby IK, Agrawal R, Mall MA, et al. miRNA-221 is elevated in cystic fibrosis airway epithelial cells and regulates expression of ATF6. Mol Cell Pediatr. 2015;2:1.
   PubMedGoogle Scholar
• Oglesby IK, Chotirmall SH, McElvaney NG, et al. Regulation of cystic fibrosis transmembrane conductance regulator by MicroRNA-145, −223, and −494 is altered in F508 cystic fibrosis airway epithelium. J Immunol. 2013;190:3354–3362.
   PubMed Web of Science ®Google Scholar
• De Santi C, Gadi S, Swiatecka-Urban A, et al. Identification of a novel functional miR-143-5p recognition element in the cystic fibrosis transmembrane conductance regulator 3′UTR. AIMS Genet. 2018;5:053–062.
   PubMed Web of Science ®Google Scholar
• Megiorni F, Cialfi S, Dominici C, et al. Synergistic post-transcriptional regulation of the cystic fibrosis transmembrane conductance regulator (CFTR) by miR-101 and miR-494 specific binding. Schrijver I, editor. PLoS One. 2011;6:e26601.
   PubMed Web of Science ®Google Scholar
• Hassan F, Nuovo GJ, Crawford M, et al. MiR-101 and miR-144 regulate the expression of the CFTR chloride channel in the lung. Kreindler JL, editor. PLoS One. 2012;7:e50837.
   PubMed Web of Science ®Google Scholar
• Gillen AE, Gosalia N, Leir S-H, et al. microRNA regulation of expression of the cystic fibrosis transmembrane conductance regulator gene. Biochem J. 2011;438:25–32.
   PubMed Web of Science ®Google Scholar
• Ramachandran S, Karp PH, Osterhaus SR, et al. Post-transcriptional regulation of cystic fibrosis transmembrane conductance regulator expression and function by microRNAs. Am J Respir Cell Mol Biol. 2013;49:544–551.
   PubMed Web of Science ®Google Scholar
• Amato F, Seia M, Giordano S, et al. Gene mutation in microRNA target sites of CFTR gene: a novel pathogenetic mechanism in cystic fibrosis? Vij N, editor. PLoS One. 2013;8:e60448.
   PubMed Web of Science ®Google Scholar
• Amato F, Tomaiuolo R, Nici F, et al. Exploitation of a very small peptide nucleic acid as a new inhibitor of miR-509-3p involved in the regulation of cystic fibrosis disease-gene expression. Biomed Res Int. 2014;2014:610718.
   PubMed Web of Science ®Google Scholar
• De Santi C, Fernández Fernández E, Gaul R, et al. Precise targeting of miRNA sites restores CFTR activity in CF bronchial epithelial cells. Mol Ther. 2020;28:1190–1199.
   PubMed Web of Science ®Google Scholar
• Fernández Fernández E, Santos-Carballal B, de Santi C, et al. Biopolymer-based nanoparticles for cystic fibrosis lung gene therapy studies. Materials (Basel, Switzerland). 2018;11:122.
   PubMed Web of Science ®Google Scholar
• O’Connor G, Krishnan N, Fagan-Murphy A, et al. Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infection. Eur J Pharm Biopharm. 2019;134:153–165.
   PubMed Web of Science ®Google Scholar